Mohammed T. Abou-Saleh

MANAGEMENT OF ACUTE MANIA 48937. Sharma V, Persad E. Augmentation of valproate with lithium in acase of rapid cycling affective disorder. Can J Psychiat 1992; 37(8):584–5.38. Pope HG, McElroy SL, Satlin A. Head injury, bipolar disorder, andresponse to valproate. Comp Psychiat 1988; 29: 34–8.39. Kando JC, Tohen M, Castillo J et al. The use of valproate in anelderly population with affective symptoms. J Clin Psychiat 1996;57(6): 238–40.40. Gnam W, Flint AJ. New onset rapid cycling bipolar disorder in an 87year old woman. Can J Psychiat 1993; 38: 324–6.41. Schneider AL, Wilcox CS. Divalproate augmentation in lithiumresistantrapid cycling mania in four geriatric patients. J Affect Disord1998; 47: 201–5.42. Mordecai DJ, Sheikh JI, Glick ID. Divalproex for the treatment ofgeriatric bipolar disorder. Int J Geriat Psychiat 1999; 14: 494–6.43. Puryear L, Kunik M, Workman JR. Tolerability of divalproexsodium in elderly psychiatric patients with mixed diagnoses. J GeriatPsychiat Neurol 1995; 8: 234–7.44. Noaghuil S, Narayan M, Nelson J. Divalproex treatment of mania inelderly patients. Am J Geriat Psychiat 1998; 6: 257–62.45. McElroy SL, Keek PE, Pope HG. Sodium valproate: its use inprimary psychiatric disorders. J Clin Psychopharmacol 1987; 7: 16–24.46. Bowden CL, Janicak PG, Orsulak P et al. Relation of serumvalproate concentration to response in mania. Am J Psychiat 1996;153(6): 765–70.47. McElroy SL, Soutullo CA, Keck PE, Kmetz GF. A pilot trial ofadjunctive gabapentin in the treatment of bipolar disorder. Ann ClinPsychiat 1997; 9: 99–103.48. Schaffer CB, Schaffer LC. Gabapentin in the treatment of bipolardisorder (letter). Am J Psychiat 1997; 154: 291–2.49. Stanton SP, Keck PE, McElroy SL. Treatment of acute mania withgabapentin (letter). Am J Psychiat 1997; 154: 287.50. Young LT, Robb JC, Patelis-Siotis I et al. Acute treatment of bipolardepression with gabapentin. Biol Psychiat 1997; 42: 851–3.51. Erfuth A, Kammerer C, Grunze H et al. An open label study ofgabapentin in the treatment of acute mania. J Psychiat Res 1998; 32:261–4.52. Hatzimanolis J, Lykouras L, Oulis P, Christodoulou GN.Gabapentin as monotherapy in the treatment of acute mania. EurNeuropsychopharmacol 1999; 9(3): 257–8.53. Riva R, Albani F, Contin M, Baruzzi A. Pharmacokineticinteractions between antiepileptic drugs. Clinical considerations.Clin Pharmacokinet 1996; 31: 470–93.54. Dichter MA, Brodie MJ. New antiepileptic drugs. N Engl J Med1996; 334: 1583–90.55. Ferrier IN. Lamotrigine and gabapentin: alternatives in the treatmentof bipolar disorder. Neuropsychobiology 1998; 38:192–7.56. Leach MJ, Marsden CM, Miller AA. Pharmacological studies onlamotrigine, a novel potential antiepileptic drug. II. Neurochemicalstudies on the mechanism of action. Epilepsia 1986; 27: 490–7.57. Xie X, Hagan RM. Cellular and molecular actions of lamotrigine:Possible mechanisms of efficacy in bipolar disorder. Neuropsychobiology1998; 38(3): 119–30.58. Sporn J, Sachs G. The anticonvulsant lamotrigine in treatmentresistantmanic-depressive illness. J Clin Psychopharmacol 1997; 17:185–9.59. Kusumakar V, Yatham LN. An open study of lamotrigine inrefractory bipolar depression. Psychiat Res 1997; 72: 145–8.60. Kusumakar V, Yatham LN. Lamotrigine treatment of rapid cyclingbipolar disorder (letter). Am J Psychiat 1997; 154: 1171–2.61. Fogelson DL, Sternbach H. Lamotrigine treatment of refractorybipolar disorder (letter). J Clin Psychiat 1997; 58: 271–3.62. Calabrese JR, Fatemi SH, Woyshville MJ. Antidepressant effects oflamotrigine in rapid cycling bipolar disorder (letter). Am J Psychiat1996; 153: 1236.63. Labbate LA, Rubey RN. Lamotrigine for treatment-refractorybipolar disorder (letter). Am J Psychiat 1997; 154: 1317.64. Walden J, Hesslinger B, van Calker D, Berger M. Addition oflamotrigine to valproate may enhance efficacy in the treatment ofbipolar affective disorder. Pharmacopsychiatry 1996; 29: 193–5.65. Bowden CL, Calabrese JR, McElroy SL et al. The efficacy oflamotrigine in rapid cycling and non-rapid cycling patients withbipolar disorder. Biol Psychiat 1999; 45(8): 953–8.66. Fatemi SH, Rappaport DJ, Calabrese JR, Thuras P. Lamotrigine inrapid-cycling bipolar disorder. J Clin Psychiat 1997; 58(12): 522–7.67. Chourinard G, Young SN, Annable L. Antimanic effect ofclonazepam. Biol Psychiat 1983; 18: 451–66.68 Bottai T, Hue B, Hillaire-Buys D et al. Clonazepam in acute mania:time-blind evaluation of clinical response and concentrations inplasma. J Affect Disord 1995; 36(1–2): 21–7.69. Sachs GS. Use of clonazepam for bipolar affective disorder. J ClinPsychiat 1990; 51(suppl): 31–34, 50–53.70. Edwards R, Stephenson U, Flewett T. Clonazepam in acute mania: adouble blind trial. Aust N Z J Psychiat 1991; 25(2): 238–42.71. Chouinard G, Annable L, Turnier L et al. A double-blindrandomized clinical trial of rapid tranquilization with i.m.clonazepam and i.m. haloperidol in agitated psychotic patients withmanic symptoms. Can J Psychiat 1993; 38(suppl 4): S114–21.72. Modell JG, Lenox RH, Weiner S. Inpatient clinical trial of lorazepamfor the management of manic agitation. J Clin Psychopharmacol 1985;5: 109–13.73. Modell JG. Further experience and observations with lorazepam inmanagement of behavioral agitation. J Clin Psychopharmacol 1986; 6:385–6.74. Lenox RH, Newhouse PA, Geelman WL, Whitaker TM. Adjunctivetreatment of manic agitation with lorazepam versus haloperidol: adouble blind study. J Clin Psychiat 1992; 53(2): 47–52.75. Lenox RH, Newhouse PA, Creelman WL, Whitaker TM. Adjunctivetreatment of manic agitation with lorazepam vs. haloperidol: adouble-blind study. J Clin Psychiat 1992; 53(2): 47–52.76. Frankenburg FR. Clozapine and bipolar disorder. J ClinPsychopharmacol 1993; 13(4): 289–90.77. Calabrese JR, Kimmel SE, Woyshville MJ et al. Clozapine fortreatment-refractory mania. Am J Psychiat 1996; 153: 759–64.78. Zarate CA Jr, Tohen M, Baldessarini RJ. Clozapine in severe mooddisorders. J Clin Psychiatry 1995; 56: 411–17.79. Zarate CA Jr, Tohen M, Banov MD. Is clozapine a mood stabilizer? JClin Psychiat 1995; 56: 108–12.80. Frye MA, Ketter TA, Altshuler LL et al. Clozapine in bipolardisorder: treatment implications for other atypical antipsychotics. JAffect Disord 1998; 48: 91–104.81. Tohen M, Sanger TM, McElroy SL et al. Olanzapine vs. placebo inthe treatment of acute mania. Am J Psychiat 1999; 156(5): 702–9.82. Mirchandani I, Young RC. Management of mania in the elderly: anupdate. Ann Clin Psychiat 1993; 5(1): 67–77.83. Cohen WF, Cohen NH. Lithium carbonate, haloperidol, andirreversible brain damage. J Am Med Assoc 1974; 230(9): 1283–7.84. Miller F, Menninger J, Whitcup SM. Lithium-neurolepticneurotoxicity in patients given lithium and a neuroleptic. HospCommun Psychiat 1987; 38(11): 1219–21.85. McCabe MS. ECT in treatment of mania, a controlled study. Am JPsychiat 1976; 133: 688–91.86. McCabe MS, Norris B. ECT vs. chlorpromazine in mania. BiolPsychiat 1977; 12: 245–54.87. Small JG, Small IF, Milstein V et al. Manic symptoms: an indicationfor bilateral ECT. Biol Psychiat 1985; 20: 125–34.88. Greenberg L, Fink M. The use of electroconvulsive therapy ingeriatric patients. Clin Geriat Med 1992; 8(2): 349–54.89. Muckherjee S, Sackeim HA, Schnur DB. Electroconvulsive therapyof acute manic episodes: a review of 50 years’ experience. Am JPsychiat 1994; 151: 169–76.90. APA Task Force Report on ECT. The Practice of ElectroconvulsiveTherapy. Recommendations for Treatment and Privileging.Washington, DC: American Psychiatric Press, 1990.91. Abrams R. Electroconvulsive Therapy, 2nd edn. New York: OxfordUniversity Press.92. Burke WJ, Rubin EH, Zorumski CF et al. The safety of ECT ingeriatric psychiatry. J Am Geriat Soc 1987; 35(6): 516–21.93. Weiner RD. The role of electroconvulsive therapy in the treatment ofdepression in the elderly. J Am Geriat Soc 1982; 30: 710–12.94. Beyer JL, Weiner RD, Glenn MD. Electroconvulsive Therapy: AProgrammed Text, 2nd edn. Washington, DC: American PsychiatricPress, 1998.95. Calabrese JR, Bowden CL, McElroy SL et al. Spectrum of activity oflamotrigine in treatment-refractory bipolar disorder. Am J Psychiat1999; 156(7): 1019–23.